-
Ensure that personnel who will perform brain
stem extractions are educated about rabies, rabies transmission and
exposure, pre-exposure vaccination and post-exposure vaccination
(PEP). (Appendix 1: Information for Workers Performing Brainstem
Extraction for Active Surveillance-Rabies in Wildlife), (Appendix 2:
Rabies Vaccine: What You Need to Know). [State Public Health
Veterinarian or designee].
-
Ensure that staff are appropriately trained
in performance of brain stem extraction procedure, including
appropriate safety precautions. [State Public Health Veterinarian or
designee].
-
Ensure personnel receiving pre-exposure
rabies vaccination are appropriately screened for contraindications
prior to vaccination and are educated about possible vaccine
reactions. [LHD Public Health Nurse].
-
Ensure personnel who are performing brain
stem extractions receive pre-exposure rabies vaccination, according to
Advisory Committee on Immunization Practices (ACIP) recommendations
(Appendix 3. MMWR: Human Rabies Prevention-United States 1999, Jan 8,
1999, vol. 48, No. RR-1). [LHD Public Health Nurse].
-
Ensure signed documentation of education,
training, pre-screening and vaccination is placed in each employees
file who receives rabies vaccine and participates in brainstem removal
activities (Appendix 4: Rabies Vaccination Checklist).
-
Submit a maximum of 8 brain stem samples per
month from each of the active surveillance counties to the Office of
Laboratory Services (OLS) for rabies testing.
-
On an annual basis educate the public about
rabies, the Oral Rabies Vaccination (ORV) program and active
surveillance , especially recognition of target species that are
potentially infected with the rabies virus.
-
On an annual basis educate local government
officials, physicians, veterinarians and the general public about the
ORV program with regard to aerial distribution and vaccine safety.
-
Ensure that all persons who receive
pre-exposure vaccination have their immune titers checked every 2
years and receive booster vaccination if titers fall below recommended
levels.
- Reduce risk of rabies exposure and disease.
- Prevent the westward spread of raccoon strain rabies in WV by
appropriate placement, determined through active surveillance, of an
ORV barrier.
-
To identify geographic location of each case
of raccoon strain rabies (RSR).
-
To determine where RSR is occurring in WV
and identify the western edge of the epizootic throughout the length
of WV.
-
Evaluate surveillance data to identify
appropriate placement for the ORV barrier.
The original focus of RSR was identified in Florida
in the 1940's and spread gradually to other nearby southern states during
the next three decades. In the late 1970's, a focus of rabies involving
raccoons was discovered on the West Virginia - Virginia border.
Epidemiologic and virologic investigations suggested that this new focus
was established due to the translocation of raccoons from the southeast
that were incubating rabies virus.
West Virginia has a population of 1.8 million people, and is one of the
two most rural states in the nation. Since raccoon rabies was first
identified within our borders in 1977, the epizootic has extended
throughout the eastern panhandle, and across the continental divide. This
epizootic now threatens the Ohio River valley leading to the Midwestern
United States; and the New River Gorge, leading to Charleston.
During the years prior to Year 2001, West Virginia had about 100 cases
of raccoon rabies per year using passive surveillance (submission of
specimens when there has been a human or domestic animal exposure).
Therefore the location of the true ‘leading edge’ of the epizootic was
unknown. During the year 2001, active surveillance was initiated in 20
West Virginia counties as part of the USDA funded Oral Rabies Vaccination
Program. These counties were chosen because they were adjacent to counties
where raccoon rabies had been identified previously. In 2002 and 2003
surveillance was extended to include 29 counties, the original 20 counties
plus 9 additional counties that were within the oral vaccine distribution
area. Active surveillance will continue in these 29 counties until
surveillance indicates otherwise. The 29 counties are:
Boone |
Kanawha |
Raleigh |
Braxton |
Lewis |
Ritchie |
Brooke |
Logan |
Roane |
Calhoun |
Marshall |
Tyler |
Clay |
McDowell |
Webster |
Doddridge |
Mercer |
Wetzel |
Fayette |
Mingo |
Wirt |
Gilmer |
Nicholas |
Wood |
Hancock |
Ohio |
Wyoming |
Harrison |
Pleasants |
|
Active surveillance during the year 2001 revealed 7 rabies positive
raccoons in 4 counties
where rabies had not been known previously (3 Raleigh, 2 Webster, 1
each in Fayette and Nicholas). In 2002, a positive raccoon was found in
Braxton County (on the border with Lewis County, a county where rabies had
been identified previously) through passive surveillance. Since 2002 no
new counties have been found positive for RSR.
Rabies is an acute viral infection of the central
nervous system that affects mammals. It is an almost invariably fatal
encephalomyelitis. In humans the encephalomyelitis is often heralded by a
sense of apprehension, headache, fever, malaise and indefinite sensory
changes often referred to the site of a preceding animal bite.
Excitability and aerophobia are frequent symptoms. The disease progresses
to paresis or paralysis; spasm of swallowing muscles leads to fear of
water (hydrophobia); delirium and convulsions follow. Without medical
intervention, the usual duration is 2 - 6 days, sometimes longer; death is
often due to respiratory paralysis.
In animals there are no known definitive or species-specific clinical
signs of rabies beyond acute behavioral alterations; "the abnormal
becomes typical". Severity and variation of signs may be related to
the specific site(s) of the primary CNS lesion. At the end of the
incubation period, the disease progresses through a short prodromal state
to encephalopathy and death, usually within days.
Initial signs of rabies are nonspecific and may include anorexia,
lethargy, fever, dysphagia, vomiting, diarrhea, straining to urinate and
defecate. Alteration in behavior, such as increasing aggressiveness and
vocalization are common. In addition to behavioral abnormalities, cranial
and peripheral nerve deficits may occur. Most animals die within one week
to 10 days of symptom onset.
Rabies virus, a rhabdovirus of the genus Lyssavirus.
All members of the genus are antigenically related, but use of monoclonal
antibodies and nucleotide sequencing of the virus demonstrates differences
according to the animal species or the geographic location from which they
originate.
The two principal rabies reservoirs found, at
present, in WV are raccoons and bats.
Rabies is transmitted by introduction of the virus
into cuts or wounds in the skin or via the mucous membranes. Bites from
infected mammals is the usual path of transmission to humans and animals.
Transmission may also occur through scratches, abrasions, open wounds or
mucus membrane that come into contact with saliva of other potentially
infectious material, such as brain tissue, from a rabid animal. Casual
contact, such as petting or touching a rabid animal, does not constitute
an exposure and is not an indication for prophylaxis.
Organ transplants taken from persons dying of undiagnosed CNS disease
have resulted in rabies in the recipients. Airborne spread has been
demonstrated in a cave where myriad of bats were roosting and in
laboratory settings, but this occurs very rarely. In the USA, rabid
insectivorous bats rarely transmit rabies to terrestrial animals, wild or
domestic.
Incubation period in humans is usually 3 - 12 weeks,
rarely as short as 9 days or as long as 7 years. Depends on the severity
of the wound, site of the wound in relation to the richness of the nerve
supply and its distance from the brain, amount and strain of virus
introduced, protection by clothing and other factors. Prolonged
incubations have occurred in prepubertal individuals.
Incubation period in most animal species is unknown. However, periods
of less than 10 days to several months are well documented. As with
humans, severe and multiple bites to the head and neck and bites to highly
innervated areas may result in shorter incubation periods.
Transmission from person to person is theoretically
possible since the saliva of the infected person may contain virus, but
this has never been documented.
Domestic dogs, cats and ferrets are the only animals with
scientifically documented viral shedding periods in saliva. Virus may be
shed for up to 10 days prior to onset of clinical signs in these animal.
There are no available data for other animal species.
Persons collecting brainstem specimens are required to obtain
pre-exposure rabies vaccination and training prior to collecting samples.
Signed documentation of vaccination and training should be placed in the
employees file (refer to Public Health Actions section)
1. Equipment
-
face shield or surgical mask and eye
goggles
-
surgical gloves (non-sterile)
-
surgical gown (if desired)
-
disposable scalpels
-
Kelly forceps
-
tweezers
-
plastic zip-lock bags
-
large trash bags
-
sharps container
-
specimen collection tins
-
Rabies specimen submission form (Appendix 5)
-
permanent marker
-
disinfectant (10% bleach solution or other
commercial disinfectant diluted according to label directions)
-
leakproof container for disinfection of
instruments
-
hand sanitizer
-
GPS unit
2. Target Species
-
Raccoons, foxes, skunks and coyotes that are
exhibiting signs consistent with rabies, found dead or as roadkill.
Signs consistent with rabies include:
-
loss of apparent wariness of humans and
domestic animals
-
unprovoked agitation and extreme
aggression toward animate or inanimate objects
-
head tilt, head pressing or butting and
"star gazing"
-
signs of self-mutilation
-
no apparent response to pain
-
paralysis of limbs and facial muscles
-
change in normal behavior patterns (i.e.,
out during daylight hours)
-
Handling target species
-
If euthanasia is necessary, it should be
performed by a professional with experience in handling or
dispatching wild animals.
-
Complete a Rabies Submission Form
(Appendix 5) for each specimen.
-
Take a GPS coordinate reading to
identify the place where the animal was found and record on the
Rabies Submission Form.
-
Allocate a unique county specific
identification number for each animal and write it on the top
right corner of the corresponding rabies submission form (there is
no official space provided on form).
-
Fill in all other information for the
specimen, human and animal exposure as appropriate.
-
Wearing gloves to prevent direct contact
with infectious materials (saliva/nervous tissue) place carcass in a
thick ply garbage bag (> 1 mil, 13 gallon garbage bags work well)
and secure shut. Double bagging may be used to transport carcass to
sample collection site. Place contaminated gloves inside the second
bag before securing shut.
-
Decontaminate all working surfaces and
equipment with disinfectant.
-
Practice proper hygiene following work with
carcasses (use alcohol based hand sanitizer or washing with soap and
water).
-
Place the Rabies Test Submission form inside
a plastic zip-lock and attach it to the bagged carcass.
3. Collection Procedure
*If there has been a human or animal exposure the entire head must
be submitted for testing.
- Put on personal protective equipment:
- face shield or surgical mask and goggles
- double glove
- surgical gown if desired
- Using a permanent marker pen label the specimen collection tin with:
- initials of person collecting brainstem
- animals county specific identification number
Open the tin and place it within easy access to the specimen
collection area.
-
With animal on its back, use a disposable
scalpel to make an incision from the tip of the lower jaw extending
approximately 2 inches below the point where head and neck join.
-
Sever the muscular attachments of the
tongue along both sides, using the lower jawbone as a guide, and
continue cutting caudally to free the larynx, trachea and esophagus as
a single unit.
-
Retract this unit to expose the ventral
surface of the spinal column and associated musculature.
-
With one hand flex the head while using a
finger from the other hand to feel the place where the head and neck
join (atlantoccipital joint).
-
Dissect tissue in order to further expose
the surface of the joint.
-
Access to brainstem appears as a
"small window" covered by a thin layer of connective tissue.
-
To increase access to the brainstem
enclosed in the boney canal joint, cut through the connective tissue
on either side of the joint while flexing the head to permit better
access.
-
The exposed brainstem/spinal cord tissue
should be cut as close to the large opening into the skull (foramen
magnum) as possible. Place the final cut to make a section of
brainstem approximately 1/4 inch.
-
Place the brainstem specimen into the
open collection tin and secure the lid. Wipe the outside of the
specimen tin with disinfectant and place it inside a plastic zip-lock.
Attach the corresponding Rabies Submission Form securely to the
specimen (either on the outside of the zip-lock or double bag the
container and place the form inside the second zip-lock).
-
The carcass and disposable personal
protection equipment (e.g., gloves and surgical gown) should be placed
into a thick ply trash bag (not a red bio-hazard bag) and discarded in
a dumpster or landfill.
-
Decontaminate all working surfaces and
equipment with disinfectant.
-
Wash hands with hand sanitizer or soap
and water.
-
Specimens should be submitted to the
Office of Laboratory Services (OLS) according to current shipping
regulations (see OLS manual). If specimens are not sent immediately to
OLS they may be stored in a regular freezer (not frost free, as
they have freeze and thaw cycles to remain frost free) for less than a
week prior to shipping.
Laboratory Criteria for Diagnosis
Brain tissue samples that are positive by immunoflourescent antibody
testing are considered diagnostic.
The standard test for detecting rabies is an immunoflourescent antibody
(IFA) test on brain tissue. Any brain tissue sample that tests positive by
IFA is considered positive for rabies and will be further tested with
monoclonal antibodies to determine which strain of rabies is involved.
Brainstem samples should be sent to the West Virginia Office of
Laboratory Services (OLS), 167 11th Ave, South Charleston, WV
25303 for testing. Sharon Hill (304-558-3530) should be contacted in
regard to questions about active surveillance testing. The specimen should
be accompanied by a completed Rabies Submission Form (Appendix 5) when
sent to the OLS.
All personnel performing brainstem extractions as a
part of active surveillance are required to receive pre-exposure
vaccination for rabies according to ACIP recommendations (Appendix 3. MMWR
Human Rabies Prevention - United States, 1999). Although pre-exposure
prophylaxis does not eliminate the need for additional therapy after a
rabies exposure, it simplifies therapy by eliminating the need for RIG and
decreasing the number of doses of vaccine needed. It may also protect
persons whose post-exposure therapy is delayed and provide protection to
persons at risk for inapparent exposures to rabies.
Prior to vaccination personnel should be screened for potential
contraindication, advised of potential adverse reactions and informed of
how to deal with reactions if they occur. Signed documentation of the
following should be placed in each participating employees file:
- education on rabies pre and post-exposure vaccination, including
screening and information on adverse reactions
- vaccine administration according to ACIP recommendations
- Pre-exposure vaccination (ACIP recommendations)
Three 1.0-mL injections of rabies vaccine should be administered
intramuscularly (deltoid area) — one
injection per day on days 0*, 7, and 21 or 28 (*day 0 is the day of the
first dose of vaccine administered).
- Precautions and Contraindications
- Immunosuppression
Corticosteroids, other
immunosuppressive agents, antimalarials, and immunosuppressive
illnesses can interfere with the development of active immunity after
vaccination. For persons with immunosuppression, pre-exposure
prophylaxis should be administered with the awareness that the immune
response might be inadequate (see Primary or Pre-exposure
Vaccination). Patients who are immunosuppressed by disease or
medications should postpone pre-exposure vaccinations and consider
avoiding activities for which rabies pre-exposure prophylaxis is
indicated. When this course is not possible, immunosuppressed persons
who are at risk for rabies should be vaccinated by the IM route and
their antibody titers checked. Failure to seroconvert after the third
dose should be managed in consultation with appropriate public health
officials (see Pre-exposure Vaccination and Serologic Testing).
Immunosuppressive agents should not be administered during
post-exposure therapy unless essential for the treatment of other
conditions. When post-exposure prophylaxis is administered to an
immunosuppressed person, it is especially important that a serum
sample be tested for rabies antibody to ensure that an acceptable
antibody response has developed.
-
Pregnancy
Because of the potential consequences of
inadequately treated rabies exposure, and because there is no indication
that fetal abnormalities have been associated with rabies vaccination,
pregnancy is not considered a contraindication to post-exposure
prophylaxis ( 117,118 ). If the risk of exposure to rabies is
substantial, pre-exposure prophylaxis might also be indicated during
pregnancy.
-
Allergies
Persons who have a history of serious hypersensitivity to rabies
vaccine should be revaccinated with caution (see Management of Adverse
Reactions).
- Management of Adverse Reactions
Once initiated, rabies prophylaxis should not be interrupted or
discontinued because of local or mild systemic adverse reactions to
rabies vaccine. Usually, such reactions can be successfully managed with
antiinflammatory and antipyretic agents, such as ibuprofen or
acetaminophen. When a person with a history of serious hypersensitivity
to rabies vaccine must be revaccinated, antihistamines can be
administered. Epinephrine should be readily available to counteract
anaphylactic reactions, and the person should be observed carefully
immediately after vaccination. Although serious systemic, anaphylactic,
or neuroparalytic reactions are rare during and after the administration
of rabies vaccines, such reactions pose a serious dilemma for the
patient and the attending physician. A patient’s risk of acquiring
rabies must be carefully considered before deciding to discontinue
vaccination.
Advice and assistance on the management of serious adverse reactions
for persons receiving rabies vaccines may be
sought from the state health department or CDC. All
serious systemic, neuroparalytic, or anaphylactic reactions should be
reported to the Vaccine Adverse Event
Reporting System (VAERS) via a 24-hour toll-free telephone number ([800]
822-7967).
- Pre-exposure Vaccination and Serologic Testing
Because the antibody response has been satisfactory after these
recommended pre-exposure prophylaxis vaccine regimens, routine
serologic testing to confirm seroconversion is not necessary except
for persons suspected of being immunosuppressed. Patients who are
immunosuppressed by disease or medications should postpone
pre-exposure vaccinations and consider avoiding activities for which
rabies pre-exposure prophylaxis is indicated. When that is not
possible, immunosuppressed persons who are at risk for exposure to
rabies should be vaccinated and their antibody titers checked. In
these cases, failures to seroconvert after the third dose should be
managed in consultation with appropriate public health officials.
- Serologic Response and Pre-exposure Booster Doses of Vaccine
Although antibody levels do not define a person’s immune status,
they are a marker of continuing immune
response. Persons who receive pre-exposure vaccination should have their
immune titers checked every 2 years and receive booster vaccination if
titers fall bellow the minimum cut off for the laboratory where testing
occurred.
Rabies titer testing should be coordinated through the Local Health
Department (Appendix 6a: Atlanta Health Associates Testing Information
and Submission Form), (Appendix 6b: Kansas State University Testing
Information).
- Post-exposure Therapy for Previously
Vaccinated Persons
If exposed to rabies, previously vaccinated persons should receive
two IM doses (1.0 mL each) of vaccine, one
immediately and one 3 days later. Previously vaccinated persons are
those who have received one of the ACIP recommended pre-exposure or
post-exposure regimens. RIG is unnecessary and should not be
administered to these persons.
-
Number of active surveillance specimens per
month sent to OLS for testing (goal is 8 brainstem submissions per
month) from each participating county
-
Proportion of submissions with GIS locating
information
-
Proportion of submissions with complete
rabies submission form
|